109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
推进癌症恶病质的理解与治疗：机制、治疗手段及未来机遇
Authors Li X, Xu T, Zhou L, Li G, Yuan Y, Song H, Liu C, Liu X
Received 21 July 2025
Accepted for publication 6 October 2025
Published 11 October 2025 Volume 2025:17 Pages 2351—2364
DOI https://doi.org/10.2147/CMAR.S555236
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Kattesh Katti
Xinyi Li,1,* Tianzhao Xu,2,* Lanmei Zhou,1 Guangli Li,3 Yiwen Yuan,3 Hui Song,4 Chang Liu,4 Xinghui Liu4
1School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, 200093, People’s Republic of China; 2Department of Central Laboratory, Zhoupu Hospital Affiliated to Shanghai University of Medicine and Health, Shanghai, 201318, People’s Republic of China; 3Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, 200135, People’s Republic of China; 4Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Xinghui Liu, Email syliuxh@163.com; Chang Liu, Email cliu94@sibs.ac.cn
Abstract: Cancer cachexia (CC) is a prevalent metabolic disorder in patients with advanced cancer, characterized by persistent skeletal muscle mass loss and irreversible body weight reduction, which significantly diminishes quality of living, therapeutic effectiveness. At present, the specific pathogenesis of CC is only defined as skeletal muscle loss induced by signaling pathways. In the clinical treatment of tumor cachexia, it has been clearly defined that there are multiple methods available for treating this disease, including nutritional therapy and exercise, but all of them have very little therapeutic effect. Surprisingly, traditional Chinese medicine has achieved initial success in treating malignant tumors, and the combined treatment of traditional Chinese and Western medicine has yielded remarkable results. Therefore, it is an urgent need to elucidate the more specific pathogenesis of CC to develop effective treatment approaches, which enhance patients’ nutritional health status as well as their overall quality of life and survival ratings. This article aims to review the pathogenesis of CC along with clinical treatment strategies and drug utilization.
Keywords: cancer, cachexia, mechanism, treatment, nutrition, Traditional Chinese medicine
1School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, 200093, People’s Republic of China; 2Department of Central Laboratory, Zhoupu Hospital Affiliated to Shanghai University of Medicine and Health, Shanghai, 201318, People’s Republic of China; 3Postgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, 200135, People’s Republic of China; 4Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Xinghui Liu, Email syliuxh@163.com; Chang Liu, Email cliu94@sibs.ac.cn
Abstract: Cancer cachexia (CC) is a prevalent metabolic disorder in patients with advanced cancer, characterized by persistent skeletal muscle mass loss and irreversible body weight reduction, which significantly diminishes quality of living, therapeutic effectiveness. At present, the specific pathogenesis of CC is only defined as skeletal muscle loss induced by signaling pathways. In the clinical treatment of tumor cachexia, it has been clearly defined that there are multiple methods available for treating this disease, including nutritional therapy and exercise, but all of them have very little therapeutic effect. Surprisingly, traditional Chinese medicine has achieved initial success in treating malignant tumors, and the combined treatment of traditional Chinese and Western medicine has yielded remarkable results. Therefore, it is an urgent need to elucidate the more specific pathogenesis of CC to develop effective treatment approaches, which enhance patients’ nutritional health status as well as their overall quality of life and survival ratings. This article aims to review the pathogenesis of CC along with clinical treatment strategies and drug utilization.
Keywords: cancer, cachexia, mechanism, treatment, nutrition, Traditional Chinese medicine